Biotricity, Inc. (BTCY)

USD 0.5

(2.04%)

Gross Profit Summary of Biotricity, Inc.

  • Biotricity, Inc.'s latest annual gross profit in 2024 was 8.35 Million USD , up 53.55% from previous year.
  • Biotricity, Inc.'s latest quarterly gross profit in 2024 FY was 8.35 Million USD , up 53.55% from previous quarter.
  • Biotricity, Inc. reported a annual gross profit of 5.44 Million USD in annual gross profit 2023, up 19.08% from previous year.
  • Biotricity, Inc. reported a annual gross profit of 4.57 Million USD in annual gross profit 2022, up 259.08% from previous year.
  • Biotricity, Inc. reported a quarterly gross profit of 1.91 Million USD for 2024 Q1, up 24.89% from previous quarter.
  • Biotricity, Inc. reported a quarterly gross profit of 2.16 Million USD for 2024 Q3, up 8.44% from previous quarter.

Annual Gross Profit Chart of Biotricity, Inc. (2024 - 2014)

Historical Annual Gross Profit of Biotricity, Inc. (2024 - 2014)

Year Gross Profit Gross Profit Growth
2024 8.35 Million USD 53.55%
2023 5.44 Million USD 19.08%
2022 4.57 Million USD 259.08%
2021 1.27 Million USD 162.0%
2020 485.77 Thousand USD 711.45%
2019 59.86 Thousand USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%

Peer Gross Profit Comparison of Biotricity, Inc.

Name Gross Profit Gross Profit Difference
Acutus Medical, Inc. -3.13 Million USD 366.378%
Cell MedX Corp. - USD -Infinity%
Dynatronics Corporation 7.63 Million USD -9.447%
Nemaura Medical Inc. -1.47 Million USD 665.993%
PetVivo Holdings, Inc. 739.52 Thousand USD -1029.951%
RetinalGenix Technologies Inc. -100.00 USD 8356381.0%
Sonendo, Inc. 10.72 Million USD 22.064%
Telesis Bio, Inc. 16.95 Million USD 50.7%
Talis Biomedical Corporation 371 Thousand USD -2152.367%
Viveve Medical, Inc. 620 Thousand USD -1247.787%